ResMed: Overview of Fiscal Second Quarter Results
ResMed Reports Strong Second Quarter Earnings
ResMed Inc., headquartered in San Diego, announced on Thursday that its net income for the fiscal second quarter reached $392.6 million.
The company reported earnings of $2.68 per share, with adjusted earnings—excluding certain one-time items—coming in at $2.81 per share.
These results surpassed analysts’ expectations, as the consensus from six analysts polled by Zacks Investment Research had predicted earnings of $2.69 per share.
ResMed, a leading provider of respiratory medical devices, also reported quarterly revenue of $1.42 billion, exceeding the $1.39 billion forecasted by seven Zacks analysts.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Vitalik Buterin backs Frame Transactions as Ethereum’s native AA debate intensifies
Royal Gold, Inc. (RGLD) CEO Highlights Strong Results at Raymond James Conference

Traders raid LME aluminum stockpiles as shortages loom
Vitalik Buterin backs Frame Transactions as Ethereum’s native AA debate intensifies
